In high-risk patients, it is now recommended to guide the intraoperative volume replacement via the stroke volume. Today, the most commonly used technique for estimating the stroke volume is the arterial waveform analysis in the radial artery. This technique has the disadvantage of being invasive and increasing the time dedicated to anesthesia during the surgery. The future is the non-invasive monitoring of stroke volume. Thus, Edwards Life Science has developed a continuous monitoring technology and non-invasive arterial pressure, cardiac output and stroke volume using a digital sensor (ClearSight®). The continuous monitoring of blood pressure by this technique was validated in cardiothoracic surgery but studies about monitoring cardiac output or stroke volume are inconclusive and contradictory. The objective of this study is to compare the use of non-invasive monitoring of stroke volume by Clearsight® with the arterial waveform analysis in the radial artery by Pulsioflex® in major surgery.
Study Type
INTERVENTIONAL
Allocation
NA
Masking
NONE
Enrollment
30
Matthieu BOISSON
Poitiers, France
Stroke Ejection Volume (SEV) measure by ClearSight®
Time frame: 24 hours
Stroke Ejection Volume (SEV) measure by Pulsioflex®
Time frame: 24 hours
Cardiac Output (CO) measure by ClearSight®
Time frame: 24 hours
Cardiac Output (CO) measure by Pulsioflex®
Time frame: 24 hours
Stroke Ejection Volume Variations (SVV) measure by ClearSight®
Time frame: 24 hours
Stroke Ejection Volume Variations (SVV) measure by Pulsioflex®
Time frame: 24 hours
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.